However, total IL-17 expression at primary and metastatic tumor sites, as shown by IL-17 mRNA transcripts were similar for both WT and STAT4 deficient tumor bearing mice, suggesting that IL-17 expression by non-T cells, which is a potentially STAT4-independent process that may be playing a role. Here, IL17A is linked to metastatic neoplasm.